Granulocyte colony stimulating factor does not induce long‐term DNA instability in healthy peripheral blood stem cell donors
Open Access
- 11 April 2003
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 73 (1) , 33-36
- https://doi.org/10.1002/ajh.10324
Abstract
To establish the safety of using G-CSF in healthy PBSC donors, we prospectively determined the degree of DNA destabilization in peripheral blood WBC. Donors were treated with SC G-CSF for 5 days. A baseline sample of peripheral blood was collected before G-CSF treatment and consecutive samples were collected on day 5, 1 month, and 2 months after treatment. The extent of double-stranded DNA relaxation and de novo synthesis of DNA was determined in each sample. We found that both parameters of DNA destabilization were significantly increased after 5 days of G-CSF and returned to baseline level at 1 and 2 months. We assume that these findings suggest that rhG-CSF administration to healthy PBSCT donors for 5 days may be a safe procedure. Am. J. Hematol. 73:33–36, 2003.Keywords
This publication has 15 references indexed in Scilit:
- Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic CancersNew England Journal of Medicine, 2001
- Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancyThe Lancet, 2001
- The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathwayOncogene, 2000
- LenograstimDrugs, 2000
- Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factorBone Marrow Transplantation, 2000
- Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor RegistryBone Marrow Transplantation, 1999
- G‐CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma and lymphomaBritish Journal of Haematology, 1996
- Long‐term safety of treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) in patients with severe congenital neutropeniasBritish Journal of Haematology, 1994
- Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity.Proceedings of the National Academy of Sciences, 1990
- Neoplastic Characteristics of the DNA Found in the Plasma of Cancer PatientsOncology, 1989